Biohaven

Biohaven

Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.

HQ location
New Haven, United States
Website
biohaven.com
Launch date
Employees
201-500 people
Market cap
$1.6b
Enterprise value
$1.5b
Share price
$15.52 BHVN
Recent deals
https://twitter.com/biohavenhttps://www.facebook.com/biohavenhttps://www.linkedin.com/company/biohaven/
Authorizing premium user...